Pay in 4 interest-free payments of $6.22 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
WADA Prohibition The World Anti-Doping Agency explicitly prohibits AOD-9604 for competitive athletes: Listed under Section S0 (Non-Approved Substances) and S2.2.3 (Growth Hormone Fragments) Prohibited at all times (both in-competition and out-of-competition) No Therapeutic Use Exemptions (TUEs) available Detection methods developed and implemented in anti-doping laboratories worldwide WADAs 2013 statement clarified that AOD-9604 is a substance still under pre-clinical and clinical development and has not been approved for therapeutic use by any government health authority in the world. Research Classification: AOD-9604 is available only for laboratory research use
A review of the effects of glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter 2 inhibitors on lean body mass in humans
For women specifically dealing with stress-related weight gain, addressing cortisol is non-negotiable
And what is the problem
In addition to being a glucagon-like peptide 1 (GLP-1) receptor agonist, like semaglutide, tirzepatide also mimics glucose-dependent insulinotropic polypeptide (GIP), a hormone involved in blood glucose regulation and the storage of excess energy in fat cells
15.0% Discount 2026-06-26 ~ 2026-09-01 Total(Qty) 0 Discounted amount of your subtotal will appear when you place your orders
US$ 22.96
US$ 23.80
US$ 26.72
